Cognetivity Sees Pilot Program Transition Into Commercial Agreement In UAE
A successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences (CSE: CGN). The firm this morning revealed
Read moreA successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences (CSE: CGN). The firm this morning revealed
Read moreWell Health Technologies (TSX: WELL) this morning attempted to rally its base amidst its endless slow selloff in the markets.
Read moreCognetivity Neurosciences (CSE: CGN) continued to take the Middle East by storm this morning. The firm has continued its pattern
Read moreThe Securities and Exchange Commission announced on Tuesday that it has filed securities fraud charges against SCWorx Corp. (Nasdaq: WORX) and
Read moreIn the wake of the consecutive resignations of its CEO and CFO, CloudMD Software & Services Inc. (TSXV: DOC) maintains
Read moreOn May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results. The company reported revenues of
Read moreThe rollout of Cognetivity Neurosciences’ (CSE: CGN) flagship product, the CognICA cognitive assessment tool, continues. The firm this morning announced
Read moreNever wanting to put a good cash-producing opportunity to waste, Well Health (TSX: WELL) this morning announced it intends to
Read moreWELL Health Technologies Corp. (TSX: WELL) reported today its financial performance for Q1 2022. The results highlighted a quarterly revenue
Read moreBausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) started trading its securities today.
Read more